Review of prescribing practices for intermittent bolus administration of morphine

Keith Sine1, Régis Vaillancourt, Elena Pascuet

  • 1, BSc(Pharm), PharmD, is with the Department of Pharmacy, Children's Hospital of Eastern Ontario, Ottawa, Ontario. At the time of the study, he was a PharmD student with the University of Toronto.

Insights

Pediatric postoperative pain management using IV morphine boluses followed standard practices. Most doses were 4 mg or less, leading to stocking only 2-mg vials and enhanced patient monitoring.

Area of Science:

  • Pediatric pharmacology
  • Pain management
  • Medication safety

Background:

  • Proposed changes to pediatric medication safety practices.
  • Focus on patient observation after opioid administration.
  • Limiting morphine concentrations in patient care units.

Purpose of the Study:

  • Document and review postoperative pain management in children.
  • Analyze intermittent intravenous (IV) bolus morphine administration.
  • Assess the impact of proposed nursing practice changes.

Main Methods:

  • Retrospective chart audit of 193 pediatric surgical patients.
  • Data collected from narcotics and controlled drug records over 3 months.
  • Included patients receiving at least two IV morphine bolus doses.

Main Results:

  • 84.5% of patients received up to 0.1 mg/kg per morphine dose.
  • Median morphine dose decreased from 0.080 mg/kg on day 1 to 0.065 mg/kg by day 5.
  • Most administered doses (78.5%) were 4 mg or less.

Conclusions:

  • Intermittent IV morphine bolus administration aligns with standard postoperative pain treatment.
  • Dose analysis informed stocking of 2-mg morphine vials.
  • Enhanced patient surveillance protocols implemented for IV morphine administration.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...